Product
Ruzasvir
Aliases
AT-038
1 clinical trial
4 indications
Indication
Chronic Hepatitis C VirusIndication
Hepatitis CIndication
ChronicIndication
CirrhosisClinical trial
A Phase 2, Open-label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic Hepatitis C Virus (HCV) InfectionStatus: Recruiting, Estimated PCD: 2024-06-01